Search

everythinglearnresearchcommunity

for

Search:↓

People with TED often have low B12 levels and might benefit from B12 supplements.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Switching from escitalopram to duloxetine helped stop hair loss.

Hirsutism significantly lowers the quality of life for Turkish women.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

CDH3-related disease causes worsening eye and hair issues.

Male pattern hair loss can cause significant emotional distress for men.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Understanding sex and gender differences can improve personalized dermatology care.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Men in the U.S. have more health issues, higher death rates from various diseases, lower life expectancy, and are less likely to seek healthcare.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Different drugs are linked to specific mental health issues.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Dermatologists are crucial in providing personalized care for patients with sex development differences.